Lyra Therapeutics (LYRA) Operating Margin (2021 - 2025)

Quarterly Operating Margin fell 9622734.0% to 101685.71% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 7794.47% through Dec 2025, down 151364.0% year-over-year, with the annual reading at 7794.47% for FY2025, 151364.0% down from the prior year.

Lyra Therapeutics' Operating Margin history spans 5 years, with the latest figure at 101685.71% for Q4 2025.

  • Operating Margin came in at 101685.71% for Q4 2025, down from 24948.0% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 2548.08% in Q1 2022 to a low of 137772.73% in Q4 2022.
  • The 5-year median for Operating Margin is 4931.81% (2025), against an average of 23017.71%.
  • Year-over-year, Operating Margin tumbled -13274025bps in 2022 and then soared 12648711bps in 2023.
  • Lyra Therapeutics' Operating Margin stood at 5032.47% in 2021, then crashed by -2638bps to 137772.73% in 2022, then soared by 92bps to 11285.62% in 2023, then soared by 52bps to 5458.37% in 2024, then plummeted by -1763bps to 101685.71% in 2025.
  • Per Business Quant, the three most recent readings for LYRA's Operating Margin are 101685.71% (Q4 2025), 24948.0% (Q3 2025), and 4822.95% (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -6.43%
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 38.10%
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 17.83%
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 23.02%
10 Lyra Therapeutics - - - -101,685.71%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -101,685.71%
Sep 30, 2025 -24,948.00%
Jun 30, 2025 -4,822.95%
Mar 31, 2025 -4,831.15%
Dec 31, 2024 -5,458.37%
Sep 30, 2024 -6,380.51%
Jun 30, 2024 -8,189.63%
Mar 31, 2024 -4,421.80%
Dec 31, 2023 -11,285.62%
Sep 30, 2023 -3,093.20%
Jun 30, 2023 -3,603.28%
Mar 31, 2023 -4,222.68%
Dec 31, 2022 -137,772.73%
Sep 30, 2022 -4,129.81%
Jun 30, 2022 -2,742.86%
Mar 31, 2022 -2,548.08%
Dec 31, 2021 -5,032.47%
Sep 30, 2021 -79,150.00%